Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director/PDMR Shareholding

23 Dec 2020 07:00

RNS Number : 6037J
Redcentric PLC
23 December 2020
 

Redcentric plc

 

Director/PDMR Shareholding, Issue of Equity and Total Voting Rights

 

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, announces that on 22 December 2020 it received notification of exercise from each of Peter Brotherton, Chief Executive Officer, and David Senior, Chief Financial Officer, in relation to nil-cost share options ("Options") over ordinary shares of 0.1p each in the Company ("Ordinary Shares"), pursuant to the Company's 2017 Long Term Incentive Plan (the "Exercise"), as follows:

· Peter Brotherton exercised 192,481 Options. Following the Exercise, Mr Brotherton sold 97,481 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Brotherton holds 228,571 Ordinary Shares in the Company (representing approximately 0.15% of the Company's issued share capital) and 921,061 share options in the Company;

· David Senior exercised 29,100 Options. Following the Exercise, Mr Senior sold 14,550 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Senior holds 43,121 Ordinary Shares in the Company (representing approximately 0.03% of the Company's issued share capital) and 249,555 shares options in the Company.

Accordingly, application has been made for 221,581 new Ordinary Shares to be issued pursuant to the option exercise to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around the 31 December 2020.

Following Admission, the Company's issued share capital will consist of 156,165,710 Ordinary Shares, 37,569 of which are held in Treasury. For reporting under the FCA's Disclosure Guidance and Transparency Rules, shareholders should exclude any shares held in Treasury and should use the figure of 156,128,141 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company.

Following the Exercise there are options outstanding over 3,891,750 Ordinary Shares, representing 2.49% of the Company's issued share capital.

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

+44 (0)800 983 2522

finnCap Ltd - Nomad and Sole Broker

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0)20 7220 0500

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Peter Brotherton

 

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

192,481 options exercised

22 December 2020

110p

97,481 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Senior

 

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

29,100 options exercised

22 December 2020

110p

14,550 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTTBJTMTTTTPM
Date   Source Headline
27th May 202512:00 pmRNSExercise of Options
27th May 20257:00 amRNSDirectorate Change
14th May 20257:00 amRNSExercise of Options
7th May 20257:00 amRNSTrading Update & CEO Appointment
25th Apr 20257:00 amRNSExercise of Options
3rd Apr 20257:00 amRNSExecutive Director Change
2nd Apr 20257:00 amRNSExercise of Options
21st Mar 20253:00 pmRNSExercise of Options
19th Feb 202512:15 pmRNSHolding(s) in Company
17th Feb 20257:00 amRNSExercise of Options
12th Feb 202511:00 amRNSExercise of Options
6th Feb 20257:00 amRNSHolding(s) in Company
5th Feb 202510:00 amRNSExercise of Options
30th Jan 20257:00 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSExercise of Options
27th Jan 20257:00 amRNSBoard Change
20th Jan 20257:00 amRNSDirectorate Change - Group CEO Appointment
6th Jan 20254:00 pmRNSExercise of Options
13th Dec 20245:00 pmRNSExercise of Options
28th Nov 20247:00 amRNSExercise of Options
20th Nov 20247:00 amRNSHalf Year Results
4th Nov 202411:45 amRNSHolding(s) in Company
4th Nov 202411:30 amRNSHolding(s) in Company
1st Nov 20247:00 amRNSBoard Changes
25th Oct 20247:00 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSExercise of Options
9th Oct 202410:15 amRNSExercise of Options
8th Oct 20247:00 amRNSSave As You Earn Share Option Scheme
4th Oct 20243:00 pmRNSExercise of Options
2nd Oct 20245:30 pmRNSExercise of Options
2nd Oct 20247:00 amRNSGrant of Options and PDMR Shareholding
1st Oct 20247:00 amRNSExercise of Options
27th Sep 20242:07 pmRNSResult of AGM
2nd Sep 20242:41 pmRNSPublication of Annual Report and Notice of AGM
23rd Aug 20242:36 pmRNSDirector/PDMR Shareholding
22nd Aug 20247:00 amRNSExercise of Options
15th Aug 20247:00 amRNSPreliminary results announcement FY24
8th Aug 20247:00 amRNSNotice of Results
7th Jun 202410:21 amRNSForm 8.5 (EPT/NON-RI)
6th Jun 20244:56 pmPRNStatement regarding Redcentric plc ("Redcentric")
6th Jun 202412:00 pmPRNForm 8.3 - Redcentric Plc
6th Jun 202410:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jun 20242:29 pmRNSForm 8.3 - Redcentric plc
5th Jun 20249:57 amPRNForm 8.3 - Redcentric Plc
5th Jun 20247:00 amRNSForm 8.3 - Redcentric PLC
4th Jun 202412:02 pmPRNForm 8.3 - Redcentric Plc
3rd Jun 20245:56 pmRNSForm 8.3 - Redcentric PLC
3rd Jun 20241:34 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
3rd Jun 202411:39 amPRNForm 8.3 - Redcentric Plc
3rd Jun 20249:20 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.